Stress Urinary Incontinence (SUI): Causes, Diagnosis, and Treatment Options
Stress Urinary Incontinence (SUI) is the involuntary leakage of urine during activities that increase intra-abdominal pressure—coughing, sneezing, laughing, lifting, or exercise. It affects an estimated 15–35% of women; it is less common in men, typically occurring post-prostatectomy.
Pathophysiology
Two primary mechanisms:
- Urethral Hypermobility: Loss of pelvic floor support allows the urethra to descend during stress, preventing adequate closure.
- Intrinsic Sphincter Deficiency (ISD): The urethral sphincter is incompetent and cannot coapt (close) properly despite adequate support.
Risk Factors
- Female sex, vaginal childbirth (especially forceps, prolonged second stage)
- Age, menopause (estrogen loss leads to mucosal atrophy)
- Obesity (increases intra-abdominal pressure)
- Chronic cough (COPD, asthma), constipation, heavy lifting
- Pelvic surgery (hysterectomy), radiation
- Neurological disorders, connective tissue disorders
- Smoking (cough, collagen degradation)
Diagnostic Evaluation
- History: Leakage triggers, volume, impact on QoL (validated questionnaires: ICIQ-UI SF, UDI-6).
- Physical Exam: Pelvic exam (POP-Q), cough stress test (supine/standing), post-void residual (PVR) measurement.
- Urinalysis/Culture: If indicated.
- Urodynamics: For complex cases (Valsalva leak point pressure, urethral pressure profilometry).
Treatment Algorithm
Conservative (First-Line)
- Pelvic Floor Muscle Training (PFMT): Kegels, biofeedback, weighted cones; 3–6 month trial.
- Lifestyle: Weight loss, smoking cessation, fluid management, treat constipation/cough.
- Vaginal Pessaries / Urethral Inserts: Mechanical support.
- Topical Estrogen: For postmenopausal women (improves mucosal integrity).
Pharmacologic
- Duloxetine (SNRI) – off-label in US; approved in EU for SUI. Modest benefit, side effects (nausea).
Surgical (Refractory Cases)
- Midurethral Sling (Retropubic/Transobturator): Gold standard; >85% cure at 1 year.
- Burch Colposuspension: Open/laparoscopic; durable but more invasive.
- Bulking Agents: For ISD; lower durability.
- Artificial Urinary Sphincter (Male SUI): High success, revision risk.
Prognosis and Follow-Up
Conservative therapy improves symptoms in 50–70%. Surgical success exceeds 80% at 5 years. Annual follow-up for symptom recurrence, mesh complications (if sling), and QoL assessment is recommended.
Urinary Disorders - Related Articles
- Understanding and Managing Bladder Control Issues in Women
- Understanding Urine Odor and Cystitis: Causes & Symptoms
- Bladder Infection Duration: Symptoms, Causes & Treatment
- Urinary Tract Infection (UTI): Home Remedies & Prevention
- Understanding Sulfur Odor in Urine: Causes & What It Means
- Medications & Urinary Incontinence: Understanding the Link
- Understanding & Diagnosing Bladder Incontinence: Symptoms & Tests
